pyrrobutamine
{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447979059
| IUPAC_name = 1-[(2E)-4-(4-chlorophenyl)-3-phenylbut-2-en-1-yl]pyrrolidine
| image = pyrrobutamine.png
| tradename =
| pregnancy_category =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 91-82-7
| ATC_prefix = R06
| ATC_suffix = AX08
| PubChem = 5284614
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1697849
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4447659
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = VE6KP18S8X
| C=20 | H=22 | Cl=1 | N=1
| smiles = C1CCN(C1)C/C=C(\CC2=CC=C(C=C2)Cl)/C3=CC=CC=C3
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI=1S/C20H22ClN/c21-20-10-8-17(9-11-20)16-19(18-6-2-1-3-7-18)12-15-22-13-4-5-14-22/h1-3,6-12H,4-5,13-16H2/b19-12+
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = WDYYVNNRTDZKAZ-XDHOZWIPSA-N
}}
Pyrrobutamine is an antihistamine and anticholinergic.{{cite journal | vauthors = Mothersill MH, Mills J, Lee HM, Anderson RC, Harris PN | title = Chemical and pharmacological characteristics of the antihistaminic compound, pyrrobutamine | journal = Annals of Allergy | volume = 11 | issue = 6 | pages = 754–7 | year = 1953 | pmid = 13114796 }}
References
{{Reflist}}
{{Antihistamines}}
{{Histamine receptor modulators}}
{{Muscarinic acetylcholine receptor modulators}}
Category:1-Pyrrolidinyl compounds
Category:4-Chlorophenyl compounds
Category:H1 receptor antagonists
Category:Muscarinic antagonists
{{respiratory-system-drug-stub}}